Blog
Latest Federal Court Cases: Merck Serono S.A. v. Hopewell Pharma Ventures, Inc.
Merck Serono S.A. v. Hopewell Pharma Ventures, Inc., Appeal Nos. 2025-1210, -1211 (Fed. Cir. Oct. 30, 2025) – In our Case of the Week, the Federal Circuit upheld a Patent Trial and Appeal Board decision invalidating claims on Merck’s multiple sclerosis drug Mavenclad®, an oral formulation of the compound cladribine….
By: Schwabe, Williamson & Wyatt PC